The board of directors of AsiaMedic Limited referred to the Company's announcement dated 30 March 2022 relating to the appointment of Mr. Kwek Zhi Bin, Arifin Kosumo ("Arifin Kwek") as the Chief Executive Officer of the Group ("CEO") with effect from 20 June 2022, and the Company's announcement dated 2 April 2022 relating to the appointment of Mr. Stanley Woo (Group Financial Controller) as the Acting Chief Operating Officer ("Acting COO") for the period from 3 April 2022 to 19 June 2022. The Board is pleased to inform that the appointment of Mr. Arifin Kwek as the CEO will take effect on 1 June 2022 (instead of 20 June 2022) and consequently, Mr. Stanley Woo will be the Acting COO until 31 May 2022 (instead of 19 June 2022).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.01 SGD | 0.00% | -9.09% | -23.08% |
Feb. 28 | Asiamedic’s Profit Declines 35% in H2 2023 Despite 24% Revenue Jump | MT |
Feb. 27 | AsiaMedic Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-23.08% | 8.47M | |
-14.92% | 84.68B | |
+13.30% | 81.12B | |
+10.92% | 29.4B | |
-12.71% | 16.73B | |
-3.06% | 16.36B | |
-2.63% | 14.92B | |
-31.75% | 11.77B | |
-1.42% | 11.72B | |
+27.44% | 11.71B |
- Stock Market
- Equities
- 505 Stock
- News AsiaMedic Limited
- Asiamedic Confirms Appointment of Arifin Kwek as CEO, Effective June 01, 2022